Showing results (81-90 of 361) with videos related to
Sort By:
Pageof 37
Investigational New Drugs|November 1, 1992
Phase II study of a combination of elliptinium and vinblastine in metastatic breast cancerL Kayitalire, F Thomas, T Le Chevalier, et al.Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 25, 2011
[Hematopoietic stem cells mobilization: state of the art in 2011 and perspectives]F Bijou, Z Ivanovic, J M Boiron, et al.Archives Internationales De Physiologie Et De Biochimie|October 1, 1982
[Relation between the electrical and mechanical activity of the stomach. In situ study of the anesthetized rat]J Thouvenot, M C de Lavernhe-Lemaire, M BoironPresse Medicale (Paris, France : 1983)|September 24, 1983
[Hodgkin's disease: analysis of a reduction of chemotherapy]C Fermé, F Teillet, M F D'Agay, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6A Harel-Bellan, A Quillet, C Marchiol, et al.European Journal of Immunology|December 1, 1986
A 93-kDa glycoprotein expressed on human cultured monocytes and dendritic reticulum cells defined by an anti-K562 monoclonal antibodyF Farace, N Kieffer, B Caillou, et al.International Journal of Cancer|May 4, 1999
Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cellsH Ardila-Osorio, B Clausse, Z Mishal, et al.Cancer Research|November 1, 1993
Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigenM Mangeney, C A Lingwood, S Taga, et al.Bulletin Du Cancer|January 1, 1982
[Salvage chemotherapy in resistant malignant lymphomas (author's transl)]T Tursz, F Ben Ayed, J P Droz, et al.The Journal of Experimental Medicine|December 1, 1979
Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector levelM Lipinski, W H Fridman, T Tursz, et al.Pageof 37